---
title: 'Systematic risk in the biopharmaceutical sector: a multiscale approach'
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-RJI2V2H6" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Uddin, G. S., Yahya, M., Bekiros, S., Jayasekera, R., &#38; Kling, G. (2021). Systematic risk in the biopharmaceutical sector: a multiscale approach. <i>Annals of Operations Research</i>. <a href="https://doi.org/10.1007/s10479-021-04402-8">https://doi.org/10.1007/s10479-021-04402-8</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-RJI2V2H6" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1963648" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/RJI2V2H6" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-RJI2V2H6" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-RJI2V2H6" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-RJI2V2H6" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://link.springer.com/content/pdf/10.1007/s10479-021-04402-8.pdf" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://link.springer.com/content/pdf/10.1007/s10479-021-04402-8.pdf" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-RJI2V2H6"></div>
</article>
<div id="csl-bib-meta-RJI2V2H6" class="csl-bib-meta">
  <article id="about-article-RJI2V2H6" class="about_pub-article">
    <h1>Om</h1>
    Uddin et al. gjennomførte ein studie for å forstå dei finansielle risikoane og avkastningane i den biopharmasøytiske sektoren samanlikna med andre typar investeringar. Dei analyserte data frå 1995 til 2019 for å sjå korleis biotek-aksjar samhandlar med ti ulike aktivaklassar over tid. Ved å bryte ned dataene i ulike tidsperiodar og frekvensar, oppdaga dei at investering i biotek kan tilby unike fordelar, spesielt i ustabile tider. Forskinga deira viser at biotek-aksjar oppfører seg annleis enn andre aktiva, noko som kan hjelpe investorar med å diversifisere porteføljane sine og potensielt forbetre dei finansielle resultata. Denne studien er viktig fordi den gir innsikt i korleis ein kan investere betre i ein høgrisikosektor som biopharmasøytisk industri.
  </article>
  <article id="keywords-article-RJI2V2H6" class="keywords-article">
    <h1>Emneord</h1>
    Systematisk risiko, Biopharmasøytisk sektor, Finansielle avkastningar, Investeringshorisontar, Diversifisering
  </article>
  <article id="abstract-article-RJI2V2H6" class="abstract-article">
    <h1>Samandrag</h1>
    It is well documented that the biopharmaceutical sector has exhibited weak financial returns,contributing to underinvestment. Innovations in the industry carry high risks; however, ananalysis of systematic risk and return compared to other asset classes is missing. This paperinvestigates the time–frequency interconnectedness between stocks in the biotech sector andten asset classes using daily cross-country data from 1995 to 2019. We capture investors’heterogeneous investment horizons by decomposing time series according to frequencies.Using a maximal overlap discrete wavelet transform (MODWT) and a dynamic conditionalcorrelation (DCC)-Student-t copula, diversification potentials are revealed, helping investorsto reap the benefits of investing in biotech. Our findings indicate that the underlying assetsexhibit nonlinear asymmetric be.havior that strengthens during periods of turmoil
  </article>
  <article id="sdg-article-RJI2V2H6" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg8" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg08_nn.png" class="image" alt="SDG 8">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=8#archive" class="sdg-publication-count"><span>461</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/anstendig-arbeid-og-oekonomisk-vekst?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div> <div id="sdg9" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg09_nn.png" class="image" alt="SDG 9">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=9#archive" class="sdg-publication-count"><span>257</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/industri-innovasjon-og-infrastruktur?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-RJI2V2H6" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=DU8Q9LN9">Handelshøgskolen Innlandet - Fakultet for økonomi og samfunnsvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3IQA89I8">Institutt for økonomifag</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=39DV3H9E">2021</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=ZCILB8E7">Desember</a></li>
    </ul>
  </article>
</div>
